Development of Escherichia coli Nissle 1917 derivative by CRISPR/Cas9 and application for gamma-aminobutyric acid (GABA) production in antibiotic-free system-Reference-Cited by-同舟云学术

Development of Escherichia coli Nissle 1917 derivative by CRISPR/Cas9 and application for gamma-aminobutyric acid (GABA) production in antibiotic-free system

Published:2021-04 Issue: Volume:168 Page:107952
ISSN:1369-703X
Container-title:Biochemical Engineering Journal
language:en
Short-container-title:Biochemical Engineering Journal

Author:

Lan Yi-Jun,Tan Shih-I^ORCID,Cheng Shu-Yun,Ting Wan-Wen,Xue Chengfeng,Lin Tzu-Han,Cai Ming-Zhi,Chen Po-Ting,Ng I-Son^ORCID

Funder

Ministry of Science and Technology, Taiwan

Publisher

Elsevier BV

Subject

Biomedical Engineering,Environmental Engineering,Bioengineering,Biotechnology

Reference45 articles.

1. Strategy for stable and high-level expression of recombinant trehalose synthase in Escherichia coli;Chen;J. Agric. Food Chem.,2012

2. Efficient biotransformation of L-lysine into cadaverine by strengthening pyridoxal 5’-phosphate-dependent proteins in Escherichia coli with cold shock treatment;Xue;Biochem. Eng. J.,2020

3. Generation of an atlas for commodity chemical production in Escherichia coli and a novel pathway prediction algorithm;Campodonico;GEM-Path. Metab. Eng.,2014

4. Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans;Elin;J. Infect. Dis.,1981

5. “Dirty little secrets”—endotoxin contamination of recombinant proteins;Wakelin;Immunol. Lett.,2006

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel heat-inducible plasmid-driven T7 system for enhancing carbonic anhydrase in engineered Escherichia coli strains;Process Biochemistry;2024-10

2. Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system;Applied and Environmental Microbiology;2024-09-10

3. Genetic heterogeneity of engineered Escherichia coli Nissle 1917 strains during scale-up simulation;Metabolic Engineering;2024-09

4. Advancements in gene editing technologies for probiotic-enabled disease therapy;iScience;2024-09

5. Utilizing Ribose 1,5-Bisphosphate Isomerase and RuBisCO-Equipped Escherichia coli Nissle for Low-Carbon Footprint GABA Production;ACS Sustainable Chemistry & Engineering;2024-07-16